US to share up to 60 million AstraZeneca vaccine doses around the world

The EU's drug regulator has been reviewing AstraZeneca's coronavirus vaccine over concerns about a very rare, but potentially fatal side effect. The European Medicines Agency (EMA) said Friday that a review of AstraZeneca's coronavirus vaccine found its benefits still outweighed the risks for adults of all age groups, despite possible links to blood clots

The President Joe Biden administration is preparing to send up to 60 million AstraZeneca doses to countries in need over the next several months, once a federal safety review is conducted, according to two senior Biden administration officials.

The company has produced about 10 million doses of the vaccine for the U.S. but the FDA has not yet authorized their use. The agency is still examining the doses to ensure they meet the necessary quality control standards. An additional 50 million doses are in production, one of the senior officials said.